Insider · CIK 0001702527
ESTES DANIEL
Reports to the SEC for 2 companies · SEATTLE, WA
Transactions
4
Companies
2
Filings
4
CIK
0001702527
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-02-27 | ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-06-11 | Sierra Oncology, Inc.Stock Option (right to buy)A Award | — |
| 2018-06-12 | Sierra Oncology, Inc.Stock Option (right to buy)A Award | — |
| 2017-05-25 | Sierra Oncology, Inc.Stock Option (Right to Buy)A Award | — |
Recent filings
- 4ESTES DANIEL0001567619-20-005544SEC(opens sec.gov)
- 4ESTES DANIEL0001209191-19-036485SEC(opens sec.gov)
- 4ESTES DANIEL0001209191-18-037795SEC(opens sec.gov)
- 4Sierra Oncology, Inc.0001209191-17-036145SEC(opens sec.gov)
Companies
Address
C/O FRAZIER HEALTHCARE PARTNERS 601 UNION STREET, SUITE 3200
SEATTLE, WA, 98101